BAG-1 interacts with the p50-p50 homodimeric NF-B complex: Implications for colorectal carcinogenesis

Oncogene

Volumn 31, Issue 22, 2012, Pages 2761-2772

  Southern, S L ^a   Collard, T J ^a   Urban, B C ^a   Skeen, V R ^a   Smartt, H J ^a   Hague, A ^a   Oakley, F ^b   Townsend, P A ^c   Perkins, N D ^b   Paraskeva, C ^a   Williams, A C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

BAG 1; Colorectal cancer; COX2; EGFR; NF kB; P50 homodimers

Indexed keywords

BAG 1 PROTEIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CANCER CELL; COLON CARCINOGENESIS; COLORECTAL CANCER; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENE SEQUENCE; GENETIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LUCIFERASES; MICE; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC; PROTEIN MULTIMERIZATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84861695017     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.452     Document Type: Article

References (66)

1. Arhel NJ, Packham G, Townsend PA, Collard TJ, H-Zadeh AM, Sharp A et al. (2003). The retinoblastoma protein interacts with BAG-1 in human colonic adenoma and carcinoma derived cell lines. Int J Cancer 106: 364-371. (Pubitemid 36870397)
2. Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE, Folsch UR et al. (2002). Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 62: 910-916. (Pubitemid 34126972)
3. Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov S, Johnson PF. (1998). Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol 18: 5678-5689. (Pubitemid 28450519)
4. Baeuerle PA, Baltimore D. (1988). I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242: 540-546. (Pubitemid 18263193)
5. Barnes JD, Arhel NJ, Lee SS, Sharp A, Al-Okail M, Packham G et al. (2005). Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis 10: 301-311. (Pubitemid 40603485)
6. Beinke S, Ley SC. (2004). Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382: 393-409. (Pubitemid 39243905)
7. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ et al. (1987). Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297. (Pubitemid 17075079)
8. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K et al. (1993). The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739. (Pubitemid 23093881)
9. Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR et al. (1999). High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer 81: 1042-1051. (Pubitemid 29516150)
10. Cancer Research UK. (2007). Bowel Cancer Factsheet. Cancer Research UK Website.
11. Cao S, Zhang X, Edwards JP, Mosser DM. (2006). NF-kappaB1 (p50) homodimers differentially regulate pro-and anti-inflammatory cytokines in macrophages. J Biol Chem 281: 26041-26050. (Pubitemid 44401810)
12. Chen LF, Greene WC. (2004). Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
13. Clemo NK, Collard TJ, Southern SL, Edwards KD, Moorghen M, Packham G et al. (2008). BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity. Carcinogenesis 29: 849-857. (Pubitemid 351494176)
14. Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R et al. (2003). The nuclear BAG-1 isoform, BAG-1 l, enhances oestrogendependent transcription. Oncogene 22: 4973-4982. (Pubitemid 37026396)
15. Deng WG, Zhu Y, Wu KK. (2003). Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J Biol Chem 278: 4770-4777. (Pubitemid 36800979)
16. Duckett CS, Perkins ND, Kowalik TF, Schmid RM, Huang ES, Baldwin Jr AS et al. (1993). Dimerization of NF-kB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).Mol Cell Biol 13: 1315-1322. (Pubitemid 23068066)
17. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U. (1992). The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 359: 339-342.
18. Froesch BA, Takayama S, Reed JC. (1998). BAG-1 l protein enhances androgen receptor function. J Biol Chem 273: 11660-11666. (Pubitemid 28272067)
19. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D. (1993). The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev 7: 1354-1363. (Pubitemid 23210884)
20. Gehring U. (2009). Multiple, but Concerted Cellular Activities of the Human Protein Hap46/BAG-1M and Isoforms. Int J Mol Sci 10: 906-928.
21. Ghosh S, May MJ, Kopp EB. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260. (Pubitemid 28183365)
22. Gilmore TD, Temin HM. (1988). v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J Virol 62: 703-714. (Pubitemid 18068624)
23. Glass CK, Rosenfeld MG. (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141. (Pubitemid 30070977)
24. Hinitt CA, Wood J, Lee SS, Williams AC, Howarth JL, Glover CP et al. (2010). BAG-1 enhances cell-cell adhesion, reduces proliferation and induces chaperone-independent suppression of hepatocyte growth factor-induced epidermal keratinocyte migration. Exp Cell Res 316: 2042-2060.
25. Hou S, Guan H, Ricciardi RP. (2003). Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding. J Biol Chem 278: 45994-45998. (Pubitemid 37432747)
26. Inan MS, Tolmacheva V, Wang QS, Rosenberg DW, Giardina C. (2000). Transcription factor NF-kappaB participates in regulation of epithelial cell turnover in the colon. Am J Physiol Gastrointest Liver Physiol 279: G1282-G1291.
27. Jiang Y, Kimchi ET, Staveley-O'Carroll KF, Cheng H, Ajani JA. (2009). Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer 115: 3609-3617.
28. Kaidi A, Williams AC, Paraskeva C. (2007). Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9: 210-217. (Pubitemid 46420864)
29. Kamens J, Richardson P, Mosialos G, Brent R, Gilmore T. (1990). Oncogenic transformation by vrel requires an amino-terminal activation domain. Mol Cell Biol 10: 2840-2847.
30. Karst AM, Gao K, Nelson CC, Li G. (2009). Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int J Cancer 124: 494-501.
31. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O et al. (1990). The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007-1018.
32. Kikuchi R, Noguchi T, Takeno S, Funada Y, Moriyama H, Uchida Y. (2002). Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. Br J Cancer 87: 1136-1139. (Pubitemid 35418109)
33. Knowlden JM, Jones HE, Barrow D, Gee JM, Nicholson RI, Hutcheson IR. (2008). Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance. Breast Cancer Res Treat 111: 79-91. (Pubitemid 352009232)
34. Lin Y, Bai L, Chen W, Xu S. (2010). The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 14: 45-55.
35. Liu R, Takayama S, Zheng Y, Froesch B, Chen GQ, Zhang X et al. (1998). Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells. J Biol Chem 273: 16985-16992. (Pubitemid 28311731)
36. Maier JV, Volz Y, Berger C, Schneider S, Cato AC. (2010). Depletion of the cellular levels of BAG-1 proteins attenuates phorbol ester-induced downregulation of IkBa and nuclear accumulation of NF-kB. Biochem Biophys Res Commun 401: 406-411.
37. Nakanishi C, Toi M. (2005). Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nature Reviews Cancer 5: 297-309. (Pubitemid 40488635)
38. Niyaz Y, Zeiner M, Gehring U. (2001). Transcriptional activation by the human Hsp70-associating protein Hap50. J Cell Sci 114: 1839-1845. (Pubitemid 32536642)
39. Packham G, Brimmell M, Cleveland JL. (1997). Mammalian cells express two differently localized BAG-1 isoforms generated by alternative translation initiation. Biochem J 328: 807-813. (Pubitemid 28005779)
40. Pahl HL. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
41. Pereira SG, Oakley F. (2008). Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 40: 1425-1430.
42. Perkins ND. (2007). Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62. (Pubitemid 46012014)
43. Rorke S, Murphy S, Khalifa M, Chernenko G, Tang SC. (2001). Prognostic significance of BAG-1 expression in nonsmall cell lung cancer. Int J Cancer 95: 317-322. (Pubitemid 32847043)
44. Rosati A, Leone A, Del Valle L, Amini S, Khalili K, Turco MC. (2007). Evidence for BAG3 modulation of HIV-1 gene transcription. J Cell Physiol 210: 676-683. (Pubitemid 46185037)
45. Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P et al. (1992). RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol 12: 674-684.
46. Schmitz ML, Baeuerle PA. (1991). The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. Embo J 10: 3805-3817. (Pubitemid 21905409)
47. Sen R, Baltimore D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716. (Pubitemid 16020062)
48. Sharp A, Crabb SJ, Townsend PA, Cutress RI, Brimmell M, Wang XH et al. (2004). BAG-1 in carcinogenesis. Expert Rev Mol Med 6: 1-15.
49. Shindoh M, Adachi M, Higashino F, Yasuda M, Hida K, Nishioka T et al. (2000). BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma. Oral Oncol 36: 444-449. (Pubitemid 30645979)
50. Smartt HJ, Elder DJ, Hicks DJ, Williams NA, Paraskeva C. (2003). Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells. Br J Cancer 89: 1358-1365. (Pubitemid 37363429)
51. Song J, Takeda M, Morimoto RI. (2001). BAG-1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat Cell Biol 3: 276-282. (Pubitemid 32201323)
52. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K et al. (1998). Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res 58: 3116-3131. (Pubitemid 28335096)
53. Takayama S, Reed JC. (2001). Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 3: E237-E241. (Pubitemid 32952248)
54. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA et al. (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80: 279-284.
55. Thornburg NJ, Pathmanathan R, Raab-Traub N. (2003). Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res 63: 8293-8301. (Pubitemid 37549481)
56. Tong X, Yin L, Washington R, Rosenberg DW, Giardina C. (2004). The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 265: 171-183. (Pubitemid 41461877)
57. Townsend PA, Stephanou A, Packham G, Latchman DS. (2005). BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol 37: 251-259. (Pubitemid 39330185)
58. Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. (2001). NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery 130: 143-150. (Pubitemid 32721661)
59. Williams AC, Browne SJ, Yeudal WA, Paterson IC, Marshall CJ, Lane DP et al. (1993). Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene 8: 3063-3072. (Pubitemid 23312912)
60. Wood J, Lee SS, Hague A. (2009). BAG-1 proteins in oral squamous cell carcinoma. Oral Oncol 45: 94-102.
61. Xiao G, Rabson AB, Young W, Qing G, Qu Z. (2006). Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 17: 281-293. (Pubitemid 44038617)
62. Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, Pater A et al. (1998). Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene 17: 981-989. (Pubitemid 28425408)
63. Yarden Y. (2001). The EGFR family and its ligands in human cancer signalling mechanisms and therapeutic opportunities. Eur J Cancer 4(Suppl): S3-S8. (Pubitemid 32938123)
64. Zeiner M, Gehring U. (1995). A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning. Proc Natl Acad Sci USA 92: 11465-11469. (Pubitemid 26014134)
65. Zeiner M, Niyaz Y, Gehring U. (1999). The hsp70-associating protein Hap46 binds to DNA and stimulates transcription. Proc Natl Acad Sci USA 96: 10194-10199. (Pubitemid 29422535)
66. Zhong H, May MJ, Jimi E, Ghosh S. (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636. (Pubitemid 34273792)